Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein

Scott A. Fulton, Scott M. Reba, Rish Pai, Meghan Pennini, Martha Torres, Clifford V. Harding, W. Henry Boom

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Alveolar macrophages constitute a primary defense against Mycobacterium tuberculosis, but they are unable to control M. tuberculosis without acquired T-cell immunity. This study determined the antigen-presenting cell function of murine alveolar macrophages and the ability of the model mycobacterium, Mycobacterium bovis BCG, to modulate it. The majority (80 to 85%) of alveolar macrophages expressed both CD80 (B7.1) and CD11c, and 20 to 30% coexpressed major histocompatibility complex II (MHC-II). Gamma interferon (IFN-γ) enhanced MHC-II but not B7.1 expression. Naive or IFN-γ-treated alveolar macrophages did not express CD86 (B7.2), CD11b, Mac-3, CD40, or F4/80. M. bovis BCG and the 19-kDa mycobacterial lipoprotein inhibited IFN-γ-regulated MHC-II expression on alveolar macrophages, and inhibition was dependent on Toll-like receptor 2. The inhibition of MHC-II expression by the 19-kDa lipoprotein was associated with decreased presentation of soluble antigen to T cells. Thus, susceptibility to tuberculosis may result from the ability of mycobacteria to interfere with MHC-II expression and antigen presentation by alveolar macrophages.

Original languageEnglish (US)
Pages (from-to)2101-2110
Number of pages10
JournalInfection and Immunity
Volume72
Issue number4
DOIs
StatePublished - Apr 1 2004
Externally publishedYes

Fingerprint

Antigen Presentation
Alveolar Macrophages
Mycobacterium bovis
Major Histocompatibility Complex
Lipoproteins
Mycobacterium
Mycobacterium tuberculosis
Interferons
T-Lymphocytes
Toll-Like Receptor 2
Antigen-Presenting Cells
Interferon-gamma
Immunity
Tuberculosis

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases

Cite this

Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein. / Fulton, Scott A.; Reba, Scott M.; Pai, Rish; Pennini, Meghan; Torres, Martha; Harding, Clifford V.; Boom, W. Henry.

In: Infection and Immunity, Vol. 72, No. 4, 01.04.2004, p. 2101-2110.

Research output: Contribution to journalArticle

Fulton, Scott A. ; Reba, Scott M. ; Pai, Rish ; Pennini, Meghan ; Torres, Martha ; Harding, Clifford V. ; Boom, W. Henry. / Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein. In: Infection and Immunity. 2004 ; Vol. 72, No. 4. pp. 2101-2110.
@article{73ae63901eee4e409388ea45e82094dd,
title = "Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein",
abstract = "Alveolar macrophages constitute a primary defense against Mycobacterium tuberculosis, but they are unable to control M. tuberculosis without acquired T-cell immunity. This study determined the antigen-presenting cell function of murine alveolar macrophages and the ability of the model mycobacterium, Mycobacterium bovis BCG, to modulate it. The majority (80 to 85{\%}) of alveolar macrophages expressed both CD80 (B7.1) and CD11c, and 20 to 30{\%} coexpressed major histocompatibility complex II (MHC-II). Gamma interferon (IFN-γ) enhanced MHC-II but not B7.1 expression. Naive or IFN-γ-treated alveolar macrophages did not express CD86 (B7.2), CD11b, Mac-3, CD40, or F4/80. M. bovis BCG and the 19-kDa mycobacterial lipoprotein inhibited IFN-γ-regulated MHC-II expression on alveolar macrophages, and inhibition was dependent on Toll-like receptor 2. The inhibition of MHC-II expression by the 19-kDa lipoprotein was associated with decreased presentation of soluble antigen to T cells. Thus, susceptibility to tuberculosis may result from the ability of mycobacteria to interfere with MHC-II expression and antigen presentation by alveolar macrophages.",
author = "Fulton, {Scott A.} and Reba, {Scott M.} and Rish Pai and Meghan Pennini and Martha Torres and Harding, {Clifford V.} and Boom, {W. Henry}",
year = "2004",
month = "4",
day = "1",
doi = "10.1128/IAI.72.4.2101-2110.2004",
language = "English (US)",
volume = "72",
pages = "2101--2110",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein

AU - Fulton, Scott A.

AU - Reba, Scott M.

AU - Pai, Rish

AU - Pennini, Meghan

AU - Torres, Martha

AU - Harding, Clifford V.

AU - Boom, W. Henry

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Alveolar macrophages constitute a primary defense against Mycobacterium tuberculosis, but they are unable to control M. tuberculosis without acquired T-cell immunity. This study determined the antigen-presenting cell function of murine alveolar macrophages and the ability of the model mycobacterium, Mycobacterium bovis BCG, to modulate it. The majority (80 to 85%) of alveolar macrophages expressed both CD80 (B7.1) and CD11c, and 20 to 30% coexpressed major histocompatibility complex II (MHC-II). Gamma interferon (IFN-γ) enhanced MHC-II but not B7.1 expression. Naive or IFN-γ-treated alveolar macrophages did not express CD86 (B7.2), CD11b, Mac-3, CD40, or F4/80. M. bovis BCG and the 19-kDa mycobacterial lipoprotein inhibited IFN-γ-regulated MHC-II expression on alveolar macrophages, and inhibition was dependent on Toll-like receptor 2. The inhibition of MHC-II expression by the 19-kDa lipoprotein was associated with decreased presentation of soluble antigen to T cells. Thus, susceptibility to tuberculosis may result from the ability of mycobacteria to interfere with MHC-II expression and antigen presentation by alveolar macrophages.

AB - Alveolar macrophages constitute a primary defense against Mycobacterium tuberculosis, but they are unable to control M. tuberculosis without acquired T-cell immunity. This study determined the antigen-presenting cell function of murine alveolar macrophages and the ability of the model mycobacterium, Mycobacterium bovis BCG, to modulate it. The majority (80 to 85%) of alveolar macrophages expressed both CD80 (B7.1) and CD11c, and 20 to 30% coexpressed major histocompatibility complex II (MHC-II). Gamma interferon (IFN-γ) enhanced MHC-II but not B7.1 expression. Naive or IFN-γ-treated alveolar macrophages did not express CD86 (B7.2), CD11b, Mac-3, CD40, or F4/80. M. bovis BCG and the 19-kDa mycobacterial lipoprotein inhibited IFN-γ-regulated MHC-II expression on alveolar macrophages, and inhibition was dependent on Toll-like receptor 2. The inhibition of MHC-II expression by the 19-kDa lipoprotein was associated with decreased presentation of soluble antigen to T cells. Thus, susceptibility to tuberculosis may result from the ability of mycobacteria to interfere with MHC-II expression and antigen presentation by alveolar macrophages.

UR - http://www.scopus.com/inward/record.url?scp=1842484130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842484130&partnerID=8YFLogxK

U2 - 10.1128/IAI.72.4.2101-2110.2004

DO - 10.1128/IAI.72.4.2101-2110.2004

M3 - Article

C2 - 15039332

AN - SCOPUS:1842484130

VL - 72

SP - 2101

EP - 2110

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 4

ER -